About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 3

A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease

A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease

NCT06493604•Aldeyra Therapeutics, Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Dry Eye Disease

Interventions

Reproxalap Ophthalmic Solution (0.25%)

Vehicle Ophthalmic Solution

Locations

1

United States

Locations (1)

Andover Eye Associates

Andover, Massachusetts, United States

Key Dates

Start Date

June 24, 2024

Primary Completion Date

February 27, 2025

Completion Date

February 27, 2025

Last Updated

December 22, 2025

Related Studies

RECRUITINGPhase 4

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

NCT07463950

Dry Eye Disease (DED)

A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.

NCT07363824

Dry Eye DiseaseIron

RECRUITINGPhase 4

Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye

NCT07396441

Juvenile Open Angle GlaucomaDry Eye Disease (DED)+3 more

Role of Corneal Nerves in Dry Eye Disease

NCT06841471

Dry Eye Disease (DED)Dry Eye+2 more

Enrolling By Invitation

Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon

NCT07268599

Dry Eye Disease (DED)

Active Not RecruitingNA

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

NCT06064071

Meibomian Gland DysfunctionDry Eye Disease

View all related studies

Sponsors

Lead Sponsor

Aldeyra Therapeutics, Inc.

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions